Collectively, AIF1 secreted by adipose-tissue macrophages is an important crosstalk mediator in the physiology of adipocytes, and AIF1 deregulation is involved in obesity, so it may be a potential therapeutic target for anti-obesity treatments. The gene discussed is AIF1; the disease is Obesity.